Formulation of nimodipine nanocrystals for oral administration.

about

Formulation of nimodipine nanocrystals for oral administration.

Item

http://www.wikidata.org/entity/Q35846349

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Formulation of nimodipine nanocrystals for oral administration.

@ast

Formulation of nimodipine nanocrystals for oral administration.

@en

type

Item

label

Formulation of nimodipine nanocrystals for oral administration.

@ast

Formulation of nimodipine nanocrystals for oral administration.

@en

prefLabel

Formulation of nimodipine nanocrystals for oral administration.

@ast

Formulation of nimodipine nanocrystals for oral administration.

@en

P1476

Formulation of nimodipine nanocrystals for oral administration.

@en

P2093

Jianwen Li

http://www.w3.org/2001/XMLSchema#string

Mo Li

http://www.w3.org/2001/XMLSchema#string

Qiang Fu

http://www.w3.org/2001/XMLSchema#string

Xiaohong Liu

http://www.w3.org/2001/XMLSchema#string

Yongjun Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial

Preparation and characterization of intravenously injectable nimodipine nanosuspension.

Production and characterization of Hesperetin nanosuspensions for dermal delivery.

A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs.

Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.

Preparation and optimization of resveratrol nanosuspensions by antisolvent precipitation using Box-Behnken design

Nanosuspensions in drug delivery.

Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.

Nanosizing--oral formulation development and biopharmaceutical evaluation.

Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case study

P2888

s12272-015-0685-5

P304

202-212

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12272-015-0685-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26584914

http://www.w3.org/2001/XMLSchema#string